As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of darker ...

Pear Therapeutics is also working on an opioid version of the cognitive behavioural therapy app, named reSET-O, for which it hopes to gain FDA approval for patients with opioid use disorder who ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

DelveInsight’s c-MET-NSCLC pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline therapies for c-MET-NSCLC treatment. The leading c-MET-NSCLC Companies such as ...

WiSA Technologies, Inc. , soon to be doing business as Datavault® AI, is introducing a fusion of its DVHolo holographic display and ADIO® technologies at New York Fashion Week (NYFW) through its ...

AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases, today announced the appointment of Matthew Hawryluk, Ph.D., MBA, as Chief ...

The stock price for Pear Therapeutics Inc Class A (OTC: PEARQ) is $0.000001 last updated May 22, 2024 at 9:30 AM EDT. Q Does Pear Therapeutics Inc Class A (PEARQ) pay a dividend?

Obesity-drug maker Metsera Inc.'s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts Friday ...

“My topical treatment pearl is ruxolitinib 1.5% cream b.i.d ... one of the authors of a recent consensus statement on the use of topical therapeutics for vitiligo in children, adolescents ...

Apple CEO Tim Cook said Apple Intelligence helped drive record iPhone upgrades over the holiday quarter.